$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Clear oil-containing pharmaceutical compositions 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/08
  • A61K-009/10
  • A61K-009/14
  • A61K-009/20
  • A61K-009/48
출원번호 US-0345615 (1999-06-30)
발명자 / 주소
  • Chen Feng-Jing
  • Patel Mahesh V.
출원인 / 주소
  • Lipocine Inc.
대리인 / 주소
    Reed
인용정보 피인용 횟수 : 306  인용 특허 : 43

초록

The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present invention include a triglyceride and a carrier, where the carrier is formed from a combination of at least tw

대표청구항

[ What is claimed and desired to be secured by United States Letters Patent is:] [1.]1. A pharmaceutical composition comprising:(a) a triglyceride;(b) a carrier comprising at least two surfactants, at least one of the surfactants being hydrophilic; and(c) a therapeutic agent which is capable of bein

이 특허에 인용된 특허 (43)

  1. Crooks Michael J. (Chatswood AUX), Clear micellized solutions of fat soluble essential nutrients.
  2. Owen Albert J. (West Chester PA) Yiv Seang H. (Wilmington DE), Convertible microemulsion formulations.
  3. Owen Albert J. (West Chester PA) Yiv Seang H. (Wilmington DE), Convertible microemulsion formulations.
  4. Owen Albert J. (West Chester PA) Yiv Seang H. (Wilmington DE) Sarkahian Ani B. (Bryn Mawr PA), Convertible microemulsion formulations.
  5. Cavanak Thomas (Biel-Benken CHX), Cyclosporin galenic forms.
  6. Woo Jong Soo (Kyunggi-do KRX), Cyclosporin soft capsule composition.
  7. Woo Jong S. (Kyunggi-do KRX), Cyclosporin-containing soft capsule compositions.
  8. Lacy Jonathan Ernest (Swindon GBX) Embleton Jonathan Kenneth (Berkshire GBX), Delivery systems for hydrophobic drugs.
  9. Wretlind Karl A. J. (Stockholm SEX) Ajaxon Bengt M. (Uppsala SEX), Emulsion for parenteral administration.
  10. Morton Frank S. S. (Seminole FL) Shelley Rickey S. (Largo FL) Patel Mahendra S. (Zaventem BEX), Enhanced solubility pharmaceutical solutions.
  11. Takada Kanji (618-2 Gokomachidori Gojoagaru Azuchi-chou Shimogyo-ku ; Kyoto-shi ; Kyoto 600 JPX), Enteric formulations of physiologically active peptides and proteins.
  12. Dell Hans-Dieter (Bergisch-Gladbach DEX) Kraus Reinhold (Cologne DEX) Schierstedt Detlef (St. Augustin DEX), Etofenamate formulation.
  13. Begum Selima (Liverpool NY) Ullah Ismat (Liverpool NY) Nunning Bernard C. (Liverpool NY), Etoposide oral dosage form.
  14. Hausheer Frederick H. ; Haridas Kochat ; Murali Dhanabalan ; Reddy Dasharatha Gauravaram, Formulations and compositions of poorly water soluble camptothecin derivatives.
  15. Cavanak Thomas (Oberwil CHX), Galenical compositions.
  16. Story Michael J. (Glenside AUX), Gelatin pharmaceutical formulations.
  17. Stone Henry D., In ovo immunization of avian embryos with oil-emulsion vaccines.
  18. Herslof Bengt (Stockholm SEX) Nicklasson Alf Gunnar Martin (Sodertalje SEX), Lipid particle forming matrix, preparation and use thereof.
  19. Modi Pankaj (1928 Main St. W. ; Apt 608 Hamilton ; Ontario CAX L8S IJ4 ) Chandarana Subash (2259 Kirkburn Drive Burlington ; Ontario CAX L7P 4E8 ), Liquid formulations for proteinic pharmaceuticals.
  20. Walch Hatto (Laupheim -Baustetten DEX) Fleck Monika (Laupheim DEX) Neuer Klaus (Grossschafhausen DEX), Liquid preparations containing cyclosporin and process for preparing same.
  21. Benita Simon (Jerusalem ILX) Levy Menashe (Jerusalem ILX), Medicinal emulsions.
  22. Takahashi Masao,JPX ; Matsushita Hiroshi,JPX, Microemulsion preparation containing a slightly absorbable substance.
  23. Yesair David W., Mixed lipid-bicarbonate colloidal particles for delivering drugs.
  24. Pittrof Folker,DEX ; Steffen Hans,CHX, Mixed micelles.
  25. Berlati Fabio (Pero ITX) Ceschel Giancarlo (Pero ITX) Roda Aldo (Pero ITX) Roda Enrico (Pero ITX) Ronchi Celestino (Pero ITX), Nor- and homo- bile acids derivatives as absorption enhancers for medicaments.
  26. Desai Ashok J. (Wilmington NC), Oral compositions of proteinaceous medicaments.
  27. Cho Moo J. ; Levy Ralph E. ; Pouletty Philippe J., Oral cyclosporin formulations.
  28. Liedtke Rainer K. (Gruenwald DEX), Oral lipid medicinal composition.
  29. Nyqvist Hkan (Tullinge SEX) Einarsson Monica (Upsala SEX) Mattsson Christer (Kungsbacka SEX), Pharmaceutical composition containing a defined lipid system.
  30. Bhalani Vinayak T. ; Patel Satishchandra P., Pharmaceutical composition for cyclosporines.
  31. Hauer Birgit (Lahr DEX) Meinzer Armin (Freiburg/Munzingen DEX) Posanski Ulrich (Freiburg DEX) Richter Friedrich (Schnbhl-Urtenen CHX), Pharmaceutical compositions comprising cyclosporins.
  32. Jones Christopher Buchan,GBX ; Platt John Henry,GBX, Pharmaceutical compositions of propofol and edetate.
  33. Story Michael J. (Threapwood GB2) Flynn Michael J. (Surrey GB2), Pharmaceutical delivery systems.
  34. Kelm Gary Robert (Cincinnati OH) Manring Gary Lee (Hamilton OH), Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery.
  35. Cho Young W. (Chester NJ) Flynn Michael John (Surrey GB2), Pharmaceutical formulations that have a biologically active hydrophilic phase and a chylomicra-containing hydrophobic ph.
  36. Muller Bernd W. W. (Schlotfeldtsberg 14a 2302 Flintbek DEX) Franzky Hans-Jurgen (von-Coels-Str. 1 5100 Aachen DEX) Klln Claus-Jurgen (Eichofstr. 9 2300 Kiel DEX), Pharmaceutical multicomponent systems and method of preparing same.
  37. Schmidt Peter C. (Marburg DEX) Stockebrand Bernd (Monchen-Gladbach DEX) Fischer Gerhard (Eberbach DEX), Pharmaceutical preparation with an active substance of low solubility in water and gastric juices.
  38. Yu Man S. (Rochester NY) Hom Foo S. (Safety Harbor FL) Chakrabarti Sibaprasanna (Oldsmer FL) Huang Chong-Heng (Madison NJ) Patel Mahendra (Swindon GB2), Solvent system enhancing the solubility of pharmaceuticals for encapsulation.
  39. Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO) Fuhrhop Ralph W. (St. Louis MO), Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same.
  40. Narayanan Kolazi S. (Palisades Park NJ), Stable, clear, efficacious aqueous microemulsion compositions containing a high loading of a water-insoluble, agricultur.
  41. Liversidge Gary G. (West Chester PA) Cundy Kenneth C. (Pottstown PA) Bishop John F. (Rochester NY) Czekai David A. (Honeoye Falls NY), Surface modified drug nanoparticles.
  42. Longenecker John P. (Mountain View CA) Ennis Richard (Fremont CA) Baldwin Patricia A. (Hayward CA) Lee William A. (Los Altos CA), Transmembrane formulations for drug administration.
  43. Yiv Seang H., Transparent liquid for encapsulated drug delivery.

이 특허를 인용한 특허 (306)

  1. Jones, Robert M.; Semple, Graeme; Fioravanti, Beatriz; Pereira, Guilherme; Calderon, Imelda; Uy, Jane Laguerta; Duvvuri, Kameshwari; Choi, Jin Sun Karoline; Xiong, Yifeng; Dave, Vibha; Azimioara, Mihai D., 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia.
  2. Du, Jinfa; Sofia, Michael Joseph, 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections.
  3. Du, Jinfa; Sofia, Michael Joseph, 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections.
  4. Tong, Ping; Zhou, Deliang; Zhang, Geoff G. Z.; Heemstra, Katherine R.; Fischer, Cristina M.; Catron, Nathaniel D.; Schmitt, Eric A.; Sanzgiri, Yeshwant D., ABT-263 capsule.
  5. Gizurarson, Sveinbjorn; Olafsdottir, Sigridur; Kristinsson, Jakob Lindal; Hrafnkelsdottir, Kolbrun; Olafsson, David Rurik; Ingolfsson, Oddur; Ingimundardottir, Ellen Ruth, Absorption promoting agent.
  6. Tygesen, Peter Holm; Lindhardt, Karsten; Olsen, Martin Rex; Fischer, Gina Engslev; Overgard, Jan Martin; Boye, Georg; Skak, Nikolaj; Elhauge, Torben, Abuse deterrent pharmaceutical compositions for controlled release.
  7. Tygesen, Peter Holm; Lindhardt, Karsten; Olsen, Martin Rex; Fischer, Gina Engslev; Overgard, Jan Martin; Boye, Georg; Skak, Nikolaj; Elhauge, Torben, Abuse-deterrent pharmaceutical compositions for controlled release.
  8. Pauls, Heinz W.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras, Acrylamide derivatives as Fab I inhibitors.
  9. Pauls, Heinz W.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras, Acrylamide derivatives as Fab I inhibitors.
  10. Wood, Willard E.; Beaverson, Neil J., Amphoteric grafted barrier materials.
  11. Parikh, Indu; Moussa, Iskandar; Carrier, Alain, Anticancer compositions.
  12. Raoof, Araz A.; Gudipati, Mangaraju; Bibby, David C.; Weinbach, Susan, Antisense permeation enhancers.
  13. Stevens, Luke Alan; Schmelzer, Wade Nolan, Aqueous dispersible sterol product.
  14. Wood, Willard E.; Bohrer, Timothy H.; Kellenberger, Stanley R.; Beaverson, Neil J., Articles having a polymer grafted cyclodextrin.
  15. Albright, Robert Bruce; Lawrence, Moses Collumbus; Sabnis, Shobhan Shashikant; Ranjan, Sivaja, Benzimidazole anthelmintic compositions.
  16. Hayes, Jon C.; Guido, Debora L.; Zupan, Jacob A., Benzimidazole non-aqueous compositions.
  17. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  18. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  19. Chen, Feng-Jing; Patel, Mahesh V.; Fikstad, David T., Clear oil-containing pharmaceutical compositions containing a therapeutic agent.
  20. Udell, Ronald G., Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing.
  21. Naidu, A. Satyanarayan; Naidu, A. G. Tezus; Naidu, A. G. Sreus, Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof.
  22. Johnson, Candace S.; Trump, Donald L., Combination chemotherapy.
  23. de Paoli Ambrosi,Gianfranco, Composition based on ethyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne.
  24. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo, Composition comprising oil drops.
  25. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo, Composition comprising oil drops.
  26. Carrara,Dario; Porto,Gabriel; Rodriguez,Jorge, Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels.
  27. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros Wanderley, Wilson, Compositions and methods for treating cardiovascular diseases.
  28. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros-Wanderley, Wilson, Compositions and methods for treating cardiovascular diseases.
  29. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros-Wanderley, Wilson, Compositions and methods for treating cardiovascular diseases.
  30. Bannister, Robin M.; Brew, John; Caparros-Wanderely, Wilson; Dilly, Suzanne J.; Pleguezeulos Mateo, Olga; Stoloff, Gregory A., Compositions and methods for treating chronic inflammation and inflammatory diseases.
  31. Bannister, Robin M.; Brew, John; Caparros-Wanderely, Wilson; Dilly, Suzanne J.; Pleguezeulos Mateo, Olga; Stoloff, Gregory A., Compositions and methods for treating chronic inflammation and inflammatory diseases.
  32. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Mateo, Olga Pleguezuelos, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  33. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  34. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  35. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  36. Bannister, Robin M.; Brew, John, Compositions and methods for treating inflammatory pain.
  37. Bannister, Robin M.; Brew, John, Compositions and methods for treating severe pain.
  38. Bannister, Robin M.; Brew, John, Compositions and methods for treating severe pain.
  39. Bannister, Robin M.; Brew, John, Compositions and methods for treating severe pain.
  40. Schramm, Jack H.; McGrath, Jr., James W., Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions.
  41. Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum, Compositions comprising multiple bioactive agents, and methods of using the same.
  42. Bromley, Philip J., Compositions containing non-polar compounds.
  43. Bromley, Philip J., Compositions containing non-polar compounds.
  44. Bromley, Philip J., Compositions containing non-polar compounds.
  45. Bromley, Philip J., Compositions containing non-polar compounds.
  46. Bromley, Philip J., Compositions containing non-polar compounds.
  47. Bromley, Philip J., Compositions containing non-polar compounds.
  48. Bromley, Philip J.; Rao, Chetan S., Compositions containing non-polar compounds.
  49. Bromley, Philip J., Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch.
  50. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros-Wanderley, Wilson, Compositions for treating cardiovascular diseases.
  51. Bannister, Robin M.; Brew, John; Caparros-Wanderely, Wilson; Dilly, Suzanne J.; Pleguezeulos Mateo, Olga; Stoloff, Gregory A., Compositions for treating chronic inflammation and inflammatory diseases.
  52. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions for treating chronic inflammation and inflammatory diseases.
  53. Hemmingsen, Pernille Hoyrup; Pedersen, Anders Vagno; Bar-Shalom, Daniel, Controlled release pharmaceutical compositions for prolonged effect.
  54. Lanzend철rfer,Ghita; Schreiner,Volker, Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives.
  55. Andrýsek, Tomá{hacek over (s)}; Vrána, Ale{hacek over (s)}, Crystallization inhibitor and its use in gelatin capsules.
  56. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  57. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  58. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  59. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  60. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  61. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  62. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  63. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  64. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  65. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  66. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  67. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  68. Shlieout, George; Koelln, Claus-Juergen; Sczesny, Frithjof; Onken, Jens; Koerner, Andreas, Delayed release pancreatin compositions.
  69. Schaeffler, Achim, Delayed-release glucocorticoid treatment of rheumatoid disease.
  70. Schaeffler, Achim, Delayed-release glucocorticoid treatment of rheumatoid disease.
  71. Tinti, Flavia Giuliana; Breitkreitz, Marcia Cristina; Matha, Vladimir; Oliani, Carlo, Delivery systems for solubilising water-insoluble pharmaceutical active ingredients.
  72. Domb,Abraham J., Dispersible concentrate for the delivery of cyclosprin.
  73. Niitsu, Yoshiro; Yu, Lei; Liu, Jian; Zhao, Gang; Ma, Nianchun; Van, Sang, Drug carriers.
  74. Ho, David Ho Sue San; Yuen, Yuen Kah Hay; Yap, Yap Siew Ping, Drug delivery system:formulation for fat-soluble drugs.
  75. Masada, Yohei; Sugita, Masaru; Kaneko, Hideki; Miyazaki, Takeshi, Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus.
  76. Chen, Feng-Jing; Patel, Mahesh V., Emulsion compositions for polyfunctional active ingredients.
  77. Basri, Mahiran; Gani, Siti Salwa Abd; Rahman, Nur Fariza Abd; Salleh, Abu Bakar; Rahman, Mohm Basyaruddin Abd; Abdul, Raja Noor Zaliha Raja, Emulsion system derived from engkabang fat esters.
  78. Wood,Willard E., Enhanced lubrication in polyolefin closure with polyolefin grafted cyclodextrin.
  79. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  80. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  81. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  82. Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.; Dewolf, Jr., Walter E.; Jakas, Dalia R., FAB I inhibitors.
  83. Burgess, Walter J.; Jakas, Dalia R.; Huffman, William F.; Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N., Fab I inhibitors.
  84. Burgess, Walter J.; Jakas, Dalia R.; Huffman, William F.; Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N., Fab I inhibitors.
  85. Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.; Dewolf, Jr., Walter E.; Jakas, Dalia R., Fab I inhibitors.
  86. Barclay, Scott Sinclair; Bosley, John Anthony; Cain, Frederick William; Koenen, Claudia; Rogers, Julia Sarah; Schmid, Ulrike, Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof.
  87. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Monica Torres, Formulations.
  88. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Mónica, Formulations.
  89. Andersen, Christine; Lindhardt, Karsten; Oevergaard, Jan Martin; Lyhne-Iversen, Louise Inoka; Olsen, Martin Rex; Haahr, Anne-Mette; Hoeyrup Hemmingsen, Pernille Kristine, Formulations and methods for the controlled release of active drug substances.
  90. Kleinman, David M.; Nivaggioli, Thierry; Gerritsen, Mary E.; Weber, David A., Formulations and methods for vascular permeability-related diseases or conditions.
  91. Kleinman, David M.; Nivaggioli, Thierry; Gerritsen, Mary E.; Weber, David A., Formulations and methods for vascular permeability-related diseases or conditions.
  92. Kleinman, David M.; Nivaggioli, Thierry; Gerritsen, Mary E.; Weber, David A., Formulations and methods for vascular permeability-related diseases or conditions.
  93. Mosher, Gerold L.; Johnson, Karen T.; Gayed, Atef A., Formulations containing amiodarone and sulfoalkyl ether cyclodextrin.
  94. Carrara,Dario Norberto R.; Grenier,Arnaud; Besse,Celine; Simes,Stephen M.; Lehman,Leah M., Formulations for transdermal or transmucosal application.
  95. Dor, Philippe J. M.; Mudumba, Sreenivasu; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq; Takhar, Sudeep, Formulations for treating ocular diseases and conditions.
  96. Bromley, Philip J., Formulations of water-soluble derivatives of vitamin E and compositions containing same.
  97. Bromley, Philip J., Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same.
  98. Jones, Robert M.; Semple, Graeme; Xiong, Yifeng; Shin, Young-Jun; Ren, Albert S.; Calderon, Imelda; Fioravanti, Beatriz; Choi, Jin Sun; Sage, Carleton R., Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto.
  99. Wood, Willard E.; Beaverson, Neil J.; Seethamraju, Kasyap V., Grafted cyclodextrin.
  100. Wood, Willard E.; Beaverson, Neil J.; Seethamraju, Kasyap V., Grafted cyclodextrin.
  101. Wood, Willard E.; Beaverson, Neil J.; Seethamraju, Kasyap V., Grafted cyclodextrin.
  102. Wood, Willard E.; Beaverson, Neil J.; Seethamraju, Kasyap V., Grafted cyclodextrin.
  103. Wood,Willard E.; Beaverson,Neil J.; Seethamraju,Kasyap V., Grafted cyclodextrin.
  104. Wood,Willard E.; Beaverson,Neil J.; Seethamraju,Kasyap V., Grafted cyclodextrin.
  105. Berman, Judd M.; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall; Manning, David Douglas; Surman, Matthew D.; Xie, Dejian; Decornez, Helene Y., Heterocyclic compounds, methods of making them and their use in therapy.
  106. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  107. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  108. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  109. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  110. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  111. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  112. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  113. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V, High-strength testosterone undecanoate compositions.
  114. Van Dyck, Stefaan M. O.; Vennekens, Bart; Coppens, Bruno; Nuyens, Filip, Hydrolyzed lecithin product to improve digestibility.
  115. Tygesen, Peter Holm; Oevergaard, Jan Martin; Oestman, Joakim, Immediate release composition resistant to abuse by intake of alcohol.
  116. Tygesen, Peter Holm; Oevergaard, Jan Martin; Oestman, Joakim, Immediate release composition resistant to abuse by intake of alcohol.
  117. Aversa, Vincenzo; Coulter, Ivan; Rosa, Mónica Torres; McDonald, Bernard Francis, Immunomodulatory compositions.
  118. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Monica Torres; Lavelle, Edward Charles, Immunomodulatory compositions comprising a polymer matrix and an oil phase.
  119. Pipkin, James D.; Zimmerer, Rupert O.; Thompson, Diane O.; Mosher, Gerold L., Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid.
  120. Pipkin, James D.; Zimmerer, Rupert O.; Thompson, Diane O.; Mosher, Gerold L., Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid.
  121. Pipkin, James D.; Zimmerer, Rupert O.; Thompson, Diane O.; Mosher, Gerold L., Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid.
  122. Mishra,Awadhesh K.; Pace,Gary W.; Vachon,Michael G, Injectable aqueous dispersions of propofol.
  123. Mishra,Awadhesh K.; Pace,Gary W.; Vachon,Michael G., Injectable aqueous dispersions of propofol.
  124. Pace, Gary W.; Vachon, Michael G.; Mishra, Awadesh K.; Snow, Robert A., Injectable dispersion of propofol.
  125. Naidu, A. Satyanarayan; Naidu, A. G. Tezus; Naidu, A. G. Sreus, Lactoferrin and angiogenin compositions and uses thereof.
  126. Plutzky, Jorge; Ziouzenkova, Ouliana, Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions.
  127. Mansour, Marc; MacDonald, Lisa Diana; Weir, Genevieve Mary; Sammatur, Leeladhar; Sharp, Kendall, Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof.
  128. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq, Liquid formulations for treatment of diseases or conditions.
  129. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq, Liquid formulations for treatment of diseases or conditions.
  130. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq, Liquid formulations for treatment of diseases or conditions.
  131. Coulter, Ivan, Manufacture of multiple minicapsules.
  132. Coulter, Ivan, Manufacture of multiple minicapsules.
  133. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Lademann, Anne-Marie, Matrix compositions for controlled delivery of drug substances.
  134. Gagnon, Lyne; Barabe, Jean; Laurin, Pierre; Penney, Christopher; Zacharie, Boulos, Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors.
  135. Penney, Christopher; Gagnon, Lyne; Laurin, Pierre; Zacharie, Boulos, Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis.
  136. Naidu, A. Satyanarayan; Naidu, A. G. Tezus; Naidu, A. G. Sreus, Metallo-lactoferrin-coenzyme compositions and methods for weight management.
  137. Naidu, A. Satyanarayan; Naidu, A.G. Tezus; Naidu, A.G. Sreus, Metallo-lactoferrin-coenzyme compositions for detoxification support.
  138. Naidu, A. Satyanarayan; Naidu, A. G. Tezus; Naidu, A. G. Sreus, Metallo-lactoferrin-coenzyme compositions to improve sleep patterns.
  139. Lehman, Leah M.; Simes, Stephen M., Method and apparatus for transdermal or transmucosal application of testosterone.
  140. Coulter, Ivan; Aversa, Vincenzo, Method for treating intestinal fibrosis.
  141. Coulter, Ivan; Aversa, Vincenzo, Method for treating intestinal fibrosis.
  142. Van dyck, Stefaan; Vennekens, Bart; Coppens, Bruno; Nuyens, Filip, Method of improving animal feeds using hydrolyzed lecithins.
  143. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  144. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  145. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  146. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  147. Lehman, Leah M.; Simes, Stephen M., Methods and apparatus for transdermal or transmucosal application of testosterone.
  148. Lederman, Seth; Harris, Herb, Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine.
  149. Lederman, Seth; Harris, Herbert, Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine.
  150. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  151. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  152. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  153. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  154. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  155. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  156. Simes, Stephen M.; Lehman, Leah M., Methods of treating hot flashes with formulations for transdermal or transmucosal application.
  157. Simes, Stephen M.; Lehman, Leah M., Methods of treating hot flashes with formulations for transdermal or transmucosal application.
  158. Fischer, Gina; Bar-Shalom, Daneil; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
  159. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
  160. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
  161. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine polymer release system.
  162. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine polymer release system.
  163. Bloom, Corey Jay; Crew, Marshall David; Smithey, Daniel Tod; Miller, Warren Kenyon; Morgen, Michael Mark, Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer.
  164. Miller, Warren Kenyon; Morgen, Michael Mark; Smithey, Daniel Tod, Nanoparticles comprising a drug, ethylcellulose, and a bile salt.
  165. Bloom, Corey Jay; Crew, Marshall David; Miller, Warren Kenyon; Morgen, Michael Mark; Smithey, Daniel Tod, Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer.
  166. Bloom, Corey J.; Crew, Marshall David; Miller, Warren Kenyon, Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer.
  167. Miller, Warren Kenyon, Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate.
  168. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  169. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  170. Nabeta, Kiichiro, Non-aqueous taxane nanodispersion formulations and methods of using the same.
  171. Bao, Donghui; Chang, Wonsuk; Nagarathnam, Dhanapalan; Sofia, Michael Joseph, Nucleoside analogs.
  172. Du, Jinfa; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph, Nucleoside cyclicphosphates.
  173. Du, Jinfa; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph, Nucleoside cyclicphosphates.
  174. Sofia, Michael Joseph; Du, Jinfa; Wang, Peiyuan; Nagarathnam, Dhanapalan, Nucleoside phosphoramidates.
  175. Sofia, Michael Joseph; Du, Jinfa; Wang, Peiyuan; Nagarathnam, Dhanapalan, Nucleoside phosphoramidates.
  176. Chang, Chin-Ming; Farnes, Eldon Q.; Olejnik, Orest; Chang, James N., Ophthalmic compositions containing loratadine.
  177. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Opioid polymer release system.
  178. Shojaei,Amir H.; Ibrahim,Scott A.; Burnside,Beth A., Oral capsule formulation with increased physical stability.
  179. Baheti, Ankit; Padhi, Bijay Kumar; Vakada, Supritha; Raghuvanshi, Rajeev Singh, Oral composition of celecoxib for treatment of pain.
  180. Baheti, Ankit; Padhi, Bijay Kumar; Vakada, Supritha; Raghuvanshi, Rajeev Singh, Oral composition of celecoxib for treatment of pain.
  181. Schramm, Jack H.; McGrath, Jr., James W., Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions.
  182. Ahmed, Salah U.; Diliberti, Charles E.; Vattikonda, Chandra; Gorukanti, Sudhir R.; Gupta, Sanjeev K., Oral dosage forms comprising progesterone and methods of making and using the same.
  183. Zerbe, Horst G.; Paiement, Nadine, Oral mucoadhesive dosage form.
  184. Coulter, Ivan, Oral pharmaceutical composition.
  185. Coulter, Ivan, Oral pharmaceutical composition.
  186. Coulter, Ivan, Oral pharmaceutical composition.
  187. Dudley, Robert E.; Constantinides, Panayiotis P., Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.
  188. Dudley, Robert E.; Constantinides, Panayiotis P., Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.
  189. Lee,Youn Joong; Choi,Won Tae; Park,Chan Woo; Kim,Byung Hoon, Output buffer circuit.
  190. Hong, Ki Whan, PTEN inhibitor or Maxi-K channels opener.
  191. Hong, Ki Whan, PTEN inhibitor or Maxi-K channels opener.
  192. Hong, Ki Whan, PTEN inhibitor or Maxi-K channels opener.
  193. Grenier,Arnaud; Carrara,Dario Norberto R.; Besse,Celine, Permeation enhancing compositions for anticholinergic agents.
  194. Dudley, Robert E.; Drouin, Dominique, Pharmaceutical composition and method for treating hypogonadism.
  195. Dudley, Robert E.; Drouin, Dominique, Pharmaceutical composition and method for treating hypogonadism.
  196. Mulye, Nirmal, Pharmaceutical composition containing water soluble drug.
  197. Mulye, Nirmal, Pharmaceutical composition containing water soluble drug.
  198. Coulter, Ivan, Pharmaceutical composition of tacrolimus.
  199. Tien, Walter L.; Graham, Richard S.; Chang, James N., Pharmaceutical compositions comprising cyclosporins.
  200. Tien,Walter L.; Graham,Richard; Chang,James N., Pharmaceutical compositions comprising cyclosporins.
  201. Miller, Warren Kenyon; Smithey, Daniel; Frankamp, Benjamin Lee; Tadday, Ralph, Pharmaceutical compositions comprising nanoparticles and a resuspending material.
  202. Bhalani, Vinayak T.; Patel, Satishchandra P., Pharmaceutical compositions for lipophilic drugs.
  203. Bhalani, Vinayak T.; Patel, Satishchandra P., Pharmaceutical compositions for lipophilic drugs.
  204. Bhalani, Vinyak T.; Patel, Satishchandra P., Pharmaceutical compositions for lipophilic drugs.
  205. Gupta,Shanker; Maurer,Barry J.; Reynolds,C. Patrick; Vishnuvajjala,B. Rao, Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same.
  206. Shlieout, George; Boedecker, Bernd; Schaefer, Siegfried; Thumbeck, Bernd; Gregory, Peter-Colin, Pharmaceutical compositions of lipase-containing products, in particular of pancreation.
  207. Carrara,R. Dario Norberto; Grenier,Arnaud; Besse,Celine, Pharmaceutical compositions of nicotine and methods of use thereof.
  208. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  209. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  210. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  211. Riley, Thomas C.; Levinson, R. Saul; Cuca, Robert C.; Mariani, Elio, Pharmaceutical delivery system.
  212. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  213. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  214. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  215. Packhaeuser, Claudia; Steiger, Norbert; Liepold, Bernd; Kostelac, Drazen; Knobloch, Martin, Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor.
  216. Chen, Hongming, Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof.
  217. Corvari,Vincent; Grandolfi,George; Parikh,Alpa, Pharmaceutical formulations of modafinil.
  218. Corvari,Vincent; Grandolfi,George; Parikh,Alpa, Pharmaceutical formulations of modafinil.
  219. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  220. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  221. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  222. DeBoeck, Arthur M.; Vanderbist, Francis; Servais, Cecile; Baudier, Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  223. Vanderbist, Francis; Servais, Cecile; Baudier, Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  224. Vanderbist, Francis; Servais, Cécile; Baudier, Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  225. Vanderbist, Francis; Servais, Cécile; Baudier, Phillippe, Pharmaceutical semi-solid composition of isotretinoin.
  226. Vanderbist,Francis; Servais,Cecile; Baudier,Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  227. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Lademann, Anne-Marie; Andersen, Christine, Polymer release system.
  228. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Lademann, Anne-Marie; Andersen, Christine, Polymer release system.
  229. Bromley, Philip J., Pre-spray emulsions and powders containing non-polar compounds.
  230. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett M.; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  231. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett M.; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  232. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  233. Domb, Abraham J.; Avramoff, Avi; Pevzner, Victor, Pro-nanodispersion for the delivery of cyclosporin.
  234. Busse, Frauke; Frink, Martin; Becher, Dietmar; Doehner, Leopold, Process for separating and determining the viral load in a pancreatin sample.
  235. Partridge, John J.; Colucci, John; Gareau, Yves; Therien, Michel; Zamboni, Robert; Hafkin, Barry; Marfat, Anthony; Zaghdane, Helmi, Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide.
  236. Partridge, John J.; Colucci, John; Gareau, Yves; Therien, Michel; Zamboni, Robert; Hafkin, Barry; Marfat, Anthony; Zaghdane, Helmi, Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide.
  237. Chang, Wonsuk; Naduthambi, Devan; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph; Zhang, Hai-Ren, Purine nucleoside phosphoramidate.
  238. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq, Rapamycin formulations and methods of their use.
  239. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq, Rapamycin formulations and methods of their use.
  240. Driscoll,David; Bistrian,Bruce, Reagents and methods for all-in-one total parenteral nutrition for neonates and infants.
  241. Kottayil, S. George; Zhu, Zhongyuan; Goskonda, Venkat R., Room-temperature stable dronabinol formulations.
  242. Borchardt, Thomas; Brackemeyer, Paul; Catron, Nathaniel; Henry, Rodger; Lou, Xiaochun; Ravn, Matthew; Zhang, Geoff G. Z.; Zhou, Deliang, Salt of ABT-263 and solid-state forms thereof.
  243. Pauls, Henry; Ramnauth, Jailall, Salts, prodrugs and polymorphs of fab I inhibitors.
  244. Pauls, Henry; Ramnauth, Jailall, Salts, prodrugs and polymorphs of fab I inhibitors.
  245. Holmberg, Christina, Self emulsifying drug delivery system.
  246. Liang,Likan; Shojaei,Amir H.; Ibrahim,Scott A.; Burnside,Beth A., Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect.
  247. Chakravorty,Saibal; Bharti,Prasad, Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities.
  248. Hojgaard, Bent, Solid oral dosage form of testosterone derivative.
  249. Zerbe, Horst; Paiement, Nadine; Angusti, Angela; Long, Cormac, Solid oral film dosage forms and methods for making same.
  250. Rosenberg, Jeorg; Reinhold, Ulrich; Liepold, Bernd; Berndl, Gunther; Breitenbach, Joerg; Alani, Laman; Ghosh, Soumojeet, Solid pharmaceutical dosage form.
  251. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  252. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  253. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  254. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  255. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  256. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  257. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  258. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  259. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  260. Fantuzzi, Michael, Solubilized CoQ-10.
  261. Fantuzzi, Michael, Solubilized CoQ-10.
  262. Fantuzzi, Michael, Solubilized CoQ-10.
  263. Fantuzzi, Michael, Solubilized CoQ-10.
  264. Fantuzzi, Michael, Solubilized CoQ-10.
  265. Fantuzzi, Michael, Solubilized CoQ-10.
  266. Fantuzzi, Michael, Solubilized CoQ-10.
  267. Herslöf, Bengt; Holmbäck, Jan, Sprayable topical carrier and composition comprising phosphatidylcholine.
  268. Catron, Nathaniel; Fickes, Michael G.; Fischer, Cristina M.; Haight, Anthony R.; Heemstra, Katherine; Sanzgiri, Yeshwant D.; Schmitt, Eric A.; Tong, Ping; Zhang, Geoff G. Z.; Zhou, Deliang, Stabilized lipid formulation of apoptosis promoter.
  269. Abramovici, Bernard; Dubois, Jean-Luc, Stable formulation containing fumagillin.
  270. Mudumba, Sreenivasu; Nivaggioli, Thierry; Takhar, Sudeep Kaur, Stable formulations, and methods of their preparation and use.
  271. Mudumba, Sreenivasu; Nivaggioli, Thierry; Takhar, Sudeep Kaur, Stable formulations, and methods of their preparation and use.
  272. Borkan, Lionel, Stable soft capsule dosage form for acetylsalicylic acid.
  273. Ross, Bruce S.; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Rachakonda, Suguna; Zhang, Hai-Ren, Stereoselective synthesis of phosphorus containing actives.
  274. Shadiack, Annette; Persicaner, Peter H. R.; Inskeep, Philip B.; Thorsteinsson, Thorsteinn; Sancilio, Frederick D.; Legassie, Jason D., Steroid hormone pharmaceutical composition.
  275. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  276. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  277. Jones, Robert M.; Lehmann, Juerg, Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto.
  278. Chun, Byoung-Kwon; Du, Jinfa; Rachakonda, Suguna; Ross, Bruce; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Chang, Wonsuk; Zhang, Hai-Ren; Nagarathnam, Dhanapalan, Synthesis of purine nucleosides.
  279. Chun, Byoung-Kwon; Du, Jinfa; Rachakonda, Suguna; Ross, Bruce; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Chang, Wonsuk; Zhang, Hai-Ren; Nagarathnam, Dhanpalan, Synthesis of purine nucleosides.
  280. Malladi, Ramana; Miller, Jodi, Testosterone gel and method of use.
  281. Malladi, Ramana; Miller, Jodi, Testosterone gel and method of use.
  282. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  283. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  284. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  285. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  286. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  287. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  288. Sargent, Bruce J.; Pauls, Henry; Berman, Judd M.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras; Martin, Fernando J.; Surman, Matthew D.; Decornez, Helene Y.; Manning, David D., Therapeutic agents, and methods of making and using the same.
  289. Merenick, Bethany Lynn; Beech, Robert P.; Reed, Thomas D.; Tretiakova, Anna P.; Peterson, Richard E., Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof.
  290. Bommarito,Alexander A., Topical antifungal treatment.
  291. Roth, Jerry, Topical liquid containing refined peanut oil for treating skin proliferation or inflammation disorders.
  292. Puglia, Nancy; Roth, Jerry; Ramirez, Rosario, Topical skin care composition.
  293. Puglia, Nancy; Roth, Jerry; Ramirez, Rosario, Topical skin care composition.
  294. Puglia, Nancy; Roth, Jerry; Ramirez, Rosario, Topical skin care composition.
  295. Puglia, Nancy; Roth, Jerry; Ramirez, Rosario, Topical skin care composition.
  296. Puglia,Nancy; Roth,Jerry; Ramirez,Rosario, Topical skin care composition containing refined peanut oil.
  297. Carrara, Dario Norberto R.; Grenier, Arnaud, Transdermal compositions for anticholinergic agents.
  298. Carrara, Dario Norberto R.; Grenier, Arnaud, Transdermal compositions for anticholinergic agents.
  299. Carrara,R. Dario Norberto; Grenier,Arnaud; Besse,Celine, Transdermal pharmaceutical formulation for minimizing skin residues.
  300. Carrara, Dario Norberto R.; Grenier, Arnaud, Transdermal testosterone formulation for minimizing skin residues.
  301. Doyle, Jr., Ralph T.; Kling, Douglas F.; Rongen, Roelof M. L.; Rotenberg, Keith S., Treating metabolic syndrome with fenofibrate.
  302. El Naggar,Mawaheb M.; Mousa,Ahmed S., Treatment of inflammatory, cancer, and thrombosis disorders.
  303. El-Naggar, Mawaheb M.; Mousa, Ahmed S., Treatment of inflammatory, cancer, and thrombosis disorders.
  304. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  305. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  306. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로